Projects funded by the NCN
Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of therapy-resistant leukemiastem-cells.
2021/43/B/NZ5/01684
Keywords:
Acute myeloid leukemia Mitochondrial metabolism Oxidative phospholiation MIA pathway APE1 Inhibitory peptide Bioinformatics drug design.
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
- NZ1_2: Biochemistry
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Hematologii i Transfuzjologii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 22 - announced on 2021-09-15
Amount awarded: 2 977 380 PLN
Project start date (Y-m-d): 2022-09-28
Project end date (Y-m-d): 2025-09-27
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.